These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
774 related items for PubMed ID: 366418
1. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. N Engl J Med; 1979 Mar 01; 300(9):452-8. PubMed ID: 366418 [Abstract] [Full Text] [Related]
3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Haematologica; 1998 Sep 01; 83(9):812-23. PubMed ID: 9825578 [Abstract] [Full Text] [Related]
4. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ, Taylor PR, Angus B, Wood K, Lennard AL, Lucraft H, Carey PJ, Stark A, Iqbal A, Haynes A, Russel N, Leonard RC, Culligan D, Conn J, Jackson GH. Eur J Haematol Suppl; 2001 Jul 01; 64():28-32. PubMed ID: 11486397 [Abstract] [Full Text] [Related]
5. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN. Cancer J Sci Am; 1995 Jul 01; 1(1):33-42. PubMed ID: 9166452 [Abstract] [Full Text] [Related]
13. [Non-Hodgkin lymphoma associated with a relapse of Hodgkin's disease]. Tertian G, Louvel A, Picard F, Varet B. Nouv Rev Fr Hematol (1978); 1983 Aug 08; 25(6):375-8. PubMed ID: 6664835 [Abstract] [Full Text] [Related]
14. Leukemia following Hodgkin's disease. Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D. N Engl J Med; 1990 Jan 04; 322(1):7-13. PubMed ID: 2403650 [Abstract] [Full Text] [Related]
15. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Zarate-Osorno A, Medeiros LJ, Kingma DW, Longo DL, Jaffe ES. Am J Surg Pathol; 1993 Feb 04; 17(2):123-32. PubMed ID: 8422110 [Abstract] [Full Text] [Related]
16. [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. Morales MD, González FA, Villegas A, del Potro E, Díaz Mediavilla J, Martínez R, Alvarez A, Colomé JA. Sangre (Barc); 1992 Dec 04; 37(6):429-33. PubMed ID: 1293793 [Abstract] [Full Text] [Related]